Free Trial

Grifols: New Gotham Article Fails To Alter Calculus on S-RAAS Deal Driving '25 Refi Events

HEALTHCARE

Grifols (GRF SM) has seen another Gotham article published this morning “How an advance payment becomes a loan Part I”. Much as this is a fun soap opera, Gotham’s claims appear increasingly immaterial and this does not alter the calculus on the key refi event (S-RAAS sale), in our view.


  • Cash pooling with Haema and the link to Scranton. The company has now clarified this situation, but it is a fair question which calls into question a range of issues around vendor- and supplier-financing which are far from unique to Grifols. Related party transactions are an issue, but Grifols does appear to be moving in the right direction on this.
  • RegFD compliance: Gotham makes a serious claim that Grifols is not in compliance with “fair disclosure” rules as Gotham appears to have learnt something from a sell-side research report. Quoting from the SEC, this pertains to “selective disclosure by issuers of material nonpublic information”. The entirety of the EUR321m pooling arrangement is 1.51% of Grifols’ Dec-23 total assets. The Corporate Finance Institute quotes 0.5% of total assets as material.
  • What does all this mean? In short, this does nothing to alter the calculus around the refi of the ’25 notes via the S-RAAS deal closure.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.